antarelix

Known as: D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-, teverelix acetate, teverelix 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2006
01219962006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Our objective was to determine the effects of the administration of growth hormone (GH) alone or plus teverelix, a gonadotrophin… (More)
Is this relevant?
2004
2004
With the objective of controlling the day of ovulation, 40 mares were assigned to a control or three treated groups: A3d, A4d… (More)
Is this relevant?
2003
2003
Teverelix microspheres were produced by coacervation using a new type of poly(ester-carbonates) made of block copolymers of poly… (More)
Is this relevant?
2003
2003
The GnRH antagonist antarelix (Teverelix) was administered to mares (0.01 mg/kg, i.v., twice a day) during the periovulatory… (More)
Is this relevant?
2000
2000
UNLABELLED BACKGROUND. Teverelix is a novel synthetic peptidic luteinizing hormone-releasing hormone (LHRH) antagonist. METHODS… (More)
Is this relevant?
1999
1999
The demonstration of an inhibitory effect of gonadotropin-releasing hormone (GnRH) agonists upon steroidogenesis in… (More)
Is this relevant?
1997
1997
The mechanism controlling luteal regression in primates is unknown but may involve cell death by apoptosis. Marmoset ovaries… (More)
Is this relevant?
1996
1996
A procedure for the radioimmunoassay (RIA) of Antarelix (teverelix) in plasma has been developed for the pharmacokinetic study of… (More)
Is this relevant?